Blockchain Registration Transaction Record
Beam Therapeutics to Present BEAM-101 Trial Data at EHA Congress 2025
Beam Therapeutics announces presentation of BEAM-101 trial data at EHA Congress 2025, highlighting the therapy's potential to provide a durable treatment for sickle cell disease. The focus on precision genetic medicines through base editing could revolutionize treatment approaches for genetic disorders.
This news matters as it showcases the potential of BEAM-101 to provide a durable treatment for sickle cell disease by presenting updated data at a prestigious medical congress. The therapy's focus on precision genetic medicines through base editing could revolutionize treatment approaches for SCD and other genetic disorders.
| Blockchain | Details |
|---|---|
| Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
| Transaction ID | 0x272b5ebd063705d99cb86d25457e53fc9d43b3cf9b1f8c0c9341f2dfd681dd92 |
| Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
| Chain | polygon-main |
| NewsRamp Digital Fingerprint | cakeWtb9-63f6917c609ac1080509ad64a7985b73 |